Multi-omics analysis of gut microbiota and gene expression reveals that TBK1 promotes colorectal tumorigenesis by activating glycolysis
Acta Microbiologica et Immunologica Hungarica · 2026
DOI: 10.1556/030.2026.02853 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Microbiologica et Immunologica Hungarica, 2026. Verfasst von Anqing Luo und 4 weiteren Autor:innen. Beteiligte Einrichtung: 1Department of General Surgery, The First Affiliated Hospital of Soochow University, No. 899 Pinghai Road, Gusu District, Suzhou City, Jiangsu Provin…. Hauptthemen laut MEDLINE: Protein Serine-Threonine Kinases, Colorectal Neoplasms, Gastrointestinal Microbiome, Glycolysis. Die Arbeit nennt 40 Literaturangaben.
Abstract (Originalsprache)
Colorectal cancer (CRC) is a prevalent malignancy with intricate connections to gut microbiota (GM) dysbiosis, though the specific mechanisms linking microbiota-induced gene expression changes to CRC progression remain unclear. This study employed a multi-omics approach to investigate the interplay between GM alterations and host gene expression in CRC. C57BL/6J male mice were used to establish CRC models via dextran sulfate sodium (DSS)/azoxymethane (AOM) induction. 16S rRNA sequencing was performed to characterize GM changes in CRC mouse models, revealing dysbiosis characterized by reduced Akkermansia muciniphila ( Akkermansia ) and elevated Desulfovibrio desulfuricans ( Desulfovibrio ) abundance. Transcriptomic analysis following microbiota transplantation identified significant upregulation of TANK-binding kinase 1 (TBK1) in CRC-associated microbiota recipients. In vitro experiments utilizing CRC cell models demonstrated that TBK1 overexpression activated glycolysis, as evidenced by increased extracellular acidification rate, lactate production, and elevated expression of glycolytic enzymes hexokinase 2 (HK2) and pyruvate dehydrogenase kinase 1 (PDK1). Functionally, TBK1 promoted cell proliferation and colony formation while inhibiting apoptosis, which were attenuated by the glycolytic inhibitor 2-deoxy-D-glucose. These findings establish TBK1 as a critical mediator linking GM dysbiosis to metabolic reprogramming in CRC, suggesting that targeting the TBK1-glycolysis axis may represent a promising therapeutic strategy for delaying CRC progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- 1Department of General Surgery, The First Affiliated Hospital of Soochow University, No. 899 Pinghai Road, Gusu District, Suzhou City, Jiangsu Province, 215006, China.
- 2Department of General Surgery, Nanjing Drum Tower Hospital Group SuQian Hospital, No.138, South Huanghe Road, Sucheng District, Suqian City, Jiangsu Province, 223800, China.
- 3Department of General Surgery,Lianshui People's Hospital of Kangda College Affiliated to Nanjing Medical University, No. 6, Hongri Avenue, Lianshui County, Huai'an City, Jiangsu Province, 223400, China.
ORCID-Profile: Xinguo Zhu
Zitieren
APA
Luo, A., Wang, J., Yao, Y., Zhang, X., & Zhu, X. (2026). Multi-omics analysis of gut microbiota and gene expression reveals that TBK1 promotes colorectal tumorigenesis by activating glycolysis. Acta Microbiologica et Immunologica Hungarica. https://doi.org/10.1556/030.2026.02853
Vancouver
Luo A, Wang J, Yao Y, Zhang X, Zhu X. Multi-omics analysis of gut microbiota and gene expression reveals that TBK1 promotes colorectal tumorigenesis by activating glycolysis. Acta Microbiologica et Immunologica Hungarica. 2026. doi:10.1556/030.2026.02853
BibTeX
@article{Luo2026,
author = {Luo, Anqing and Wang, Jian and Yao, Yizhou and Zhang, Xishan and Zhu, Xinguo},
title = {Multi-omics analysis of gut microbiota and gene expression reveals that TBK1 promotes colorectal tumorigenesis by activating glycolysis},
journal = {Acta Microbiologica et Immunologica Hungarica},
year = {2026},
doi = {10.1556/030.2026.02853}
}
EUVIMED